Star Holdings filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission, disclosing a net loss attributable to common shareholders of $45.1 million for the third quarter.
Opaleye Management Inc., Opaleye, L.P., and James Silverman filed Amendment No. 10 to their beneficial ownership statement with the SEC on November 6, 2026, reporting a combined 2,105,000 shares of Harrow, Inc. common stock as of September 30, 2026.
Kestrel Group Ltd filed its third-quarter 2026 earnings release on November 6, 2026, reporting Program Services fee income of $2.9 million, a net loss of $16.4 million, and ongoing cost-reduction initiatives expected to generate approximately $5 million in annualized run-rate savings.
Karpus Management, Inc. filed Amendment No. 3 to a Schedule 13G with the SEC on November 6, 2026, reporting beneficial ownership of 1,378,327 shares of common stock of Charlton Aria Acquisition Corp, representing 26.31% of the class, as of an event date of October …
Karpus Management, Inc. filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of preferred shares of Eagle Point Income Co as of October 30, 2026.
Opaleye Management Inc., Opaleye, L.P., and James Silverman filed Amendment No. 5 to their Schedule 13G with the SEC on November 6, 2026, disclosing a beneficial ownership position in Codexis, Inc. common stock as of September 30, 2026.
Karpus Management, Inc. filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 1,766,134 shares of common stock in East West Ave Acquisition Corp., representing 16.97% of the class, based on an event date of October 30, 2026.
Eagle Point Credit Management LLC filed Amendment No. 5 to its Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of Preferred Shares of Carlyle Credit Income Fund as of September 30, 2026.
Opaleye Management Inc., Opaleye, L.P., and James Silverman filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing their beneficial ownership of common stock in Gossamer Bio, Inc. as of September 30, 2026.
Opaleye Management Inc., Opaleye, L.P., and James Silverman filed an amended beneficial ownership statement with the SEC on November 6, 2026, disclosing that as of September 30, 2026, they collectively held zero shares of Pasithea Therapeutics Corp. common stock.